CB

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 1999, for ACE Limited (Note: The input text identifies the registrant as ACE Limited, despite the user metadata referencing Chubb Ltd). ACE is a holding company providing a broad range of insurance and reinsurance products through subsidiaries in Bermuda, the U.S. (ACE USA), the U.K. (Lloyd's), and Ireland. A material event during this period was the January 12, 1999, announcement of an agreement to acquire CIGNA Corporation's property and casualty businesses for $3.45 billion, expected to close by July 1, 1999.

Key Financial Metrics

Material Changes vs. Prior Period

• Premium Growth: Gross premiums written increased 46.5% to $689.6 million for the six-month period, driven by the inclusion of the CAT Limited portfolio (merged into Tempest Re), increased participation in Lloyd's syndicates, and growth at ACE USA.
• Investment Performance: Net investment income rose 20.9% due to a larger asset base. However, net realized gains decreased to $147.4 million from $173.1 million, primarily due to lower gains on equity securities compared to the prior year's liquidation of domestic stock portfolios.
• Underwriting Results: The combined ratio improved to 84.7% from 81.5% in the prior year. The loss and loss expense ratio decreased to 53.3% (from 59.1%), while the expense ratio increased to 31.4% (from 22.4%) due to costs associated with diversification and Lloyd's participation.
• Cash Flow: Net cash used in operating activities was $148.2 million, a significant shift from the $254.6 million provided in the prior year. This was largely due to $240 million in breast implant claim payments and timing of loss payments.

Outlook, Risks, and Contingencies

• CIGNA Acquisition: The company plans to finance the $3.45 billion CIGNA acquisition using available cash, interim bank financing, and permanent financing via new equity, debt, and convertible securities. National Indemnity (Berkshire Hathaway) is providing $1.25 billion in protection against adverse loss reserve development.
• Breast Implant Claims: The company has paid approximately $610 million to date, including $240 million in the current six-month period. Management believes reserves are adequate and future material impact is unlikely, though uncertainties remain.
• Asbestos and Environmental: Reserves are maintained based on known facts and current law, though estimation remains challenging due to the inadequacy of traditional actuarial methods for these exposures.
• Year 2000 Issue: The company is executing a remediation project with an estimated total cost of $4 million. Management expects the project to be substantially complete by September 30, 1999, and believes the risk of material adverse effect is minimized.
• Dividends: A quarterly dividend of $0.11 per share was declared on May 7, 1999, payable July 16, 1999.

Investor Verification Checklist

• Verify the regulatory approval status and closing timeline for the $3.45 billion CIGNA acquisition.
• Review the adequacy of reserves for breast implant, asbestos, and environmental claims given the historical volatility in these areas.
• Assess the impact of the $240 million breast implant cash outflow on future liquidity and operating cash flows.
• Monitor the integration of the CAT Limited portfolio and its effect on the combined ratio and loss volatility.
• Confirm the status of the Year 2000 remediation project and the readiness of key trading partners.